Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical is currently trading at Rs. 625.00, up by 15.20 points or 2.49% from its previous closing of Rs. 609.85 on the BSE.

The scrip opened at Rs. 616.00 and has touched a high and low of Rs. 629.90 and Rs. 614.55 respectively. So far 32,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 643.00 on 29-Jun-2012 and a 52 week low of Rs. 448.20 on 04-Oct-2011.

Last one week high and low of the scrip stood at Rs. 629.90 and Rs. 605.55 respectively. The current market cap of the company is Rs. 64,727 crore.

The promoters holding in the company stood at 63.72% while Institutions and Non-Institutions held 25.73% and 10.55% respectively.

The company’s net profit for the fourth quarter ended March 31, 2012 rose 88.31% to Rs 702.00 crore as compared to Rs 372.78 crore for the quarter ended March 31, 2011. The total income has increased by 60.04% to Rs 1388.68 crore for the quarter under review from Rs 867.72 crore for the corresponding quarter of the previous year.

For the year ended March 31, 2012, the company’s net profit jumped by 39.33% to Rs 1927.98 crore as compared to Rs 1383.80 crore for the previous year. The company’s total income has increased by 30.33% to Rs 4303.91 crore for the year from Rs 3302.30 crore in the previous year.

On consolidated basis, the Group’s net profit after tax and minority interest stood at Rs 2587.25 crore for the year under review as compared to Rs 1816.06 crore for the period ago, up by 42.47%. Its total income has increased by 38.51% to Rs 8429.69 crore for the year ended March 31, 2012 from Rs 6085.75 crore in the previous year.